Evaluation of efficacy of mammalian and baculovirus expressed E2 subunit vaccine candidates to bovine viral diarrhoea virus

Vaccine

Volumn 27, Issue 17, 2009, Pages 2387-2393

  Thomas, Carole ^a   Young, Natalie J ^a   Heaney, Judith ^a   Collins, Margaret E ^a   Brownlie, Joe ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Baculovirus; BVDV; E2; Heterologous protein expression; Vaccine

Indexed keywords

BACULOVIRUS E2 PROTEIN; GLYCOPROTEIN E2; MAMMALIAN E2 PROTEIN; NEUTRALIZING ANTIBODY; QUIL A; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; BOVINE DIARRHEA VIRUS; CATTLE DISEASE; CONTROLLED STUDY; DRUG EFFICACY; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VACCINATION; VIRUS SHEDDING;

ANIMALS; ANTIBODY FORMATION; BACULOVIRIDAE; BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE; CATTLE; CELL LINE; DIARRHEA VIRUS 1, BOVINE VIRAL; NASOPHARYNX; RECOMBINANT PROTEINS; VACCINES, SUBUNIT; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES; VIRUS SHEDDING;

EID: 62249087822     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.02.010     Document Type: Article

References (32)

1. Ridpath J.F. BVDV genotypes and biotypes: practical implications for diagnosis and control. Biologicals 31 (2003) 127-131
2. Brownlie J. The pathways for bovine virus diarrhoea virus biotypes in the pathogenesis of disease. Arch Virol Suppl 3 (1991) 79-96
3. Heinz F., Collett M., Purrchell R., Gould E., Howard C., Houghton M., et al. Family Flaviviridae. In: van Regnmortel M.H.V., Fanqute C.M., Bishop D.H.L., Carstens E.V., Estes M.K., Lemon S.M., Manilott J., Mayo M.A., McGeoch D.J., Pringle C.R., and Wickner R.B. (Eds). Virus taxonomy, Proceedings of the seventh report of the International Committee on Taxonomy of Viruses (2000), Academic Press 859-878
4. Collett M., Larson R., Belzer S.K., and Retzel E. Proteins encoded by bovine viral diarrhea virus: the genomic organization of a pestivirus. Virology 165 (1988) 200-208
5. Thiel H.J., Meyers G., Stark R., Tautz N., Rumenapf T., Unger G., et al. Molecular characterisation of positive-strand RNA viruses: pestiviruses and the porcine reproductive and respiratory syndrome virus (PRRSV). Arch Virol Suppl 7 (1993) 41-52
6. Donis R.O., Corapi W.V., and Dubovi E.J. Neutralising monoclonal antibodies to bovine viral diarrhoea virus bind to the 56K to 58K glycoprotein. J Gen Virol 69 (1988) 77-86
7. Bruschke C.J., Moormann R.J., van Oirschot J.T., and van Rijn P.A. A subunit vaccine based on glycoprotein E2 of bovine viral diarrhea virus induces fetal protection in sheep against homologous challenge. Vaccine 15 (1997) 1940-1945
8. Bolin S.R., and Ridpath J.F. Glycoprotein E2 of bovine viral diarrhea virus expressed in insect cells provides calves limited protection from systemic infection and disease. Arch Virol 141 (1996) 1463-1477
9. Elahi S.M., Shen S.H., Talbot B.G., Massie B., Harpin A., and Elazhary Y. Recombinant adenoviruses expressing the E2 protein of bovine viral diarrhea virus induce humoral and cellular immune responses. FEMS Microbiol Lett 177 (1999) 159-166
10. Harpin S., Hurley D.J., Mbikay M., Talbot B., and Elazhary Y. Vaccination of cattle with DNA plasmid enoding the bovine viral diarrhoea virus major glycoprotein E2. J Gen Virol 80 (1999) 3137-3140
11. Nobiron I., Thompson I., Brownlie J., and Collins M.E. Co-administration of IL-2 enhances antigen specific immune responses following vaccination with DNA encoding the glycoprotein E2 of bovine viral diarrhoea virus. Vet Microbiol 76 (2000) 129-142
12. Nobiron I., Thompson I., Brownlie J., and Collins M.E. DNA vaccination against bovine viral diarrhea virus induces humoral and cellular responses in cattle with evidence for protection against viral challenge. Vaccine 21 (2003) 2082-2092
13. Liang R., van den Hurk J.V., Zheng C., Yu H., Pontarollo R.A., Babiuk L.A., et al. Immunization with plasmid DNA encoding a truncated, secreted form of the bovine viral diarrhea virus E2 protein elicits strong humoral and cellular immune responses. Vaccine 23 (2005) 5252-5262
14. Liang R., van den Hurk J.V., Babiuk L.A., and van Drunen Littel-van den Hurk S. Priming with DNA encoding E2 and boosting with E2 protein formulated with CpG oligodeoxynucleotides induces strong immune responses and protection from Bovine viral diarrhea virus in cattle. J Gen Virol 87 (2006) 2971-2982
15. Possee R.D. Baculoviruses as expression vectors. Curr Opin Biotechnol 8 (1997) 569-572
16. Jarvis D.L. Developing baculovirus-insect cell expression systems for humanized recombinant glycoprotein production. Virology 310 (2003) 1-7
17. van Oers M.M. Vaccines for viral and parasitic diseases produced with baculovirus vectors. Adv Virus Res 68 (2006) 193-253
18. Harrison R.L., and Jarvis D.L. Protein N-glycosylation in the baculovirus-insect cell expression system and engineering of insect cells to produce 'mammalianised' recombinant glycoproteins. Adv Virus Res 68 (2006) 159-191
19. Kim Y.K., Shin H.S., Tomiya N., Lee Y.C., Betenbaugh M.J., and Cha H.J. Production and N-glycan analysis of secreted human erythropoietin in stably transfected Drosophila S2 cells. Biotechnol Bioeng 92 (2005) 452-461
20. Sethuraman N., and Stadheim T.A. Challenges in therapeutic glycoprotein production. Current Opin Biotechnol 17 (2006) 341-346
21. Goffard A., and Dubuisson J. Glycosylation of hepatitis C virus envelope proteins. Biochimie 85 (2003) 295-301
22. Kowalski J., Gilbert S.A., van Drunen-Littel van den Hurk S., van den Hurk J., Babiuk L.A., and Zamb T.J. Heat-shock promoter-driven synthesis of secreted bovine herpesvirus glycoproteins in transfected cells. Vaccine 11 (1993) 1100-1107
23. Howard C.J., Clarke M.C., and Brownlie J. An enzyme-linked immune-sorbent assay (ELISA) for the detection of antibodies to bovine viral diarrhoea virus (BVDV) in cattle sera. Vet Microbiol 10 (1985) 359-369
24. Howard C.J., Brownlie J., and Clarke M.C. Comparison by the neutralisation assay of pairs of pairs of non-cytopathogenic and cytopathogenic strains of bovine viral diarrhoea virus isolated from cases of mucosal disease. Vet Microbiol 13 (1987) 361-369
25. Howard C.J., Clarke M.C., and Brownlie J. Protection against respiratory infection with bovine virus diarrhoea virus by passively acquired antibody. Vet Microbiol 19 (1989) 195-203
26. Ridpath J.F., Neill J.D., Endsley J., and Roth J.A. Effect of passive immunity of the development of a protective immune response against bovine viral diarrhea virus in calves. Am J Vet Res 64 (2003) 65-69
27. Shiu J.S., Liu S.T., Chang T.J., Ho W.C., Lai S.S., and Chang Y.S. The presence of RNA splicing signals in the cDNA construct of the E2 gene of classical swine fever virus affected its expression. J Virol Meth 69 (1997) 223-230
28. Tate C.G., Haase J., Baker C., Boorsma M., Magnani F., Vallis Y., et al. Comparison of seven different heterologous protein expression systems for the production of the serotonin transporter. Biochim Biophys Acta 1610 (2003) 141-153
29. Pande A., Carr B.V., Wong S.Y.C., Dalton K., Jones I.M., McCauley J.W., et al. The glycosylation pattern of baculovirus expressed envelope protein E2 affects its ability to prevent infection with bovine viral diarrhoea virus. Virus Res 114 (2005) 54-62
30. Jarvis D.L., and Summers M.D. Glycosylation and secretion of human tissue plasminogen activator in recombinant baculovirus-infected insect cells. Mol Cell Biol 9 (1989) 214-223
31. James D.C., Freedman R.B., Hoare M., Ogonah O.W., Rooney B.C., Larionov O.A., et al. N-glycosylation of recombinant human interferon-gamma produced in different animal expression systems. Biotechnology 13 (1995) 592-596
32. Raju T.S., Lerner L., and O'Connor J.V. Glycopinion: biological significance and methods for the analysis of complex carbohydrates of recombinant glycoproteins. Biotechnol Appl Biochem 24 (1996) 191-194